Working… Menu

Gemcitabine With or Without Cisplatin in Treating Patients With Unresectable Locally Advanced or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors (ABC-02)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00262769
Recruitment Status : Completed
First Posted : December 7, 2005
Last Update Posted : July 17, 2012
Eli Lilly and Company
Information provided by (Responsible Party):
University College, London